로딩 중…
지수 로딩 중…
Absci Corporation
ABSI· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$7.41+3.20%
2026-06-18
Price Chart
Absci Corporation+169.45%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.16B |
| Revenue | $2M |
| Net Income | $-118M |
| Total Assets | $196M |
| Net Assets | $172M |
| Value | |
| P/B | 6.72x |
| P/S | 629.22x |
| FCF Yield | -8.53% |
| Profitability | |
| ROE | -68.87% |
| ROA | -60.55% |
| Op. Margin | -7000.82% |
| Revenue Growth | -81.76% |
| Financial Health | |
| Debt Ratio | 13.74% |
| Total Debt | $4M |
| FCF | $-99M |
| Cash | $9M |
| Current Ratio | 6.59x |
| Performance | |
| 1Y Return | 169.45% |
| 1M Return | 60.04% |
| From 52W High | -9.30% |
| 1Y MDD | -54.00% |
| Trading | |
| Volume | 7,854,723 shares |
| Trading Value | $58M |
| Per Share | |
| EPS | $-0.60 |
| BPS | $1.46 |